Pharmacokinetics and endometrial tissue concentrations of enrofloxacin and the metabolite ciprofloxacin after i.v. administration of enrofloxacin to mares

Journal of Veterinary Pharmacology and Therapeutics

Volumn 25, Issue 5, 2002, Pages 343-350

  Papich, Mark G ^a   Van Camp, S D ^a   Cole, J A ^a   Whitacre, M D ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DRUG METABOLITE; ENROFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL INFECTION; BLOOD SAMPLING; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG PENETRATION; ENDOMETRIUM; ENDOMETRIUM BIOPSY; FEMALE; GRAM NEGATIVE BACTERIUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORSE; MAXIMUM ALLOWABLE CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIPROFLOXACIN; ENDOMETRIUM; FEMALE; FLUOROQUINOLONES; HORSES; INFUSIONS, INTRAVENOUS; QUINOLONES;

ANIMALIA; BACTERIA (MICROORGANISMS); EQUUS CABALLUS; NEGIBACTERIA;

EID: 0036441182     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.2002.00434.x     Document Type: Article

References (30)

1. Bermingham, E.C., Papich, M.G. & Vivrette, S.L. (2000) Pharmacokinetics of enrofloxacin administered intravenously and orally to foals. American Journal of Veterinary Research, 61, 706-709.
2. Bertone, A.L., Tremaine, W.H., Macoris, D.G., Simmons, E.J., Ewert, K.M., Herr, L.G. & Weisbrode, S.E. (2000) Effect of long-term administration of an injectable enrofloxacin solution on physical and musculoskeletal variables in adult horses. Journal of the American Veterinary Medical Association, 217, 1514-1521.
3. Bidgood, T. & Papich, M.G. (2002) Plasma pharmacokinetics and tissue fluid concentrations of meropenem after intravenous and subcutaneous administration in dogs. American Journal of Veterinary Research. (in press)
4. Boeckh, C., Buchanan, C., Boeckh, A., Wilkie, S., Davis, C., Buchanan, T. & Boothe, D.M. (2001) Pharmacokinetics of the bovine formulation of enrofloxacin (Baytril 100) in horses. Veterinary Therapeutics, 2, 129-134.
5. Cester, C.C., Schneider, M. & Toutain, P.-L. (1996) Comparative kinetics of two orally administered fluoroquinolones in dog: Enrofloxacin versus marbofloxacin. Revue Méd Vét, 147, 703-716.
6. Dowling, P.M., Wilson, R.C., Tyler, J.W. & Duran, S.H. (1995) Pharmacokinetics of ciprofloxacin in ponies. Journal of Veterinary Pharmacology and Therapeutics, 18, 7-12.
7. Gibaldi, M. & Perrier, D. (1982) Pharmacokinetics, 2nd Edn. Marcel Dekker, Inc., New York, 494 pp.
8. Giguère, S., Sweeney, R.W. & Bèlanger, M. (1996) Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses. American Journal of Veterinary Research, 57, 1025-1030.
9. Giguère, S., Sweeney, R.W., Habecker, P.L., Lucas, J. & Richardson, D.W. (1999) Tolerability of orally administered enrofloxacin in adult horses: A pilot study. Journal of Veterinary Pharmacology and Therapeutics, 22, 343-347.
10. Gough, A.W., Kasali, O.B., Sigler, R.E. & Baragi, V. (1992) Quinolone arthropathy - Acute toxicity to immature articular cartilage. Toxicologic Pathology, 20, 436-447.
11. Haines, G.R., Brown, M.P., Gronwall, R.R. & Merritt, K.A. (2000) Serum concentrations and pharmacokinetics of enrofloxacin after intravenous and intragastric administration to mares. Canadian Journal of Veterinary Research, 64, 171-177.
12. Höffken, G., Lode, H., Prinzinger, C., Prinzing, C., Borner, K. & Koeppe, P. (1985) Pharmacokinetics of ciprofloxacin after oral parenteral administration. Antimicrobial Agents and Chemotherapy, 27, 375-379.
13. Hyatt, J.M., McKinnon, P.S., Zimmer, G.S. & Schentag, J.J. (1995) The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Clinical Pharmacokinetics, 28, 143-160.
14. Joos, B., Ledergerber, B., Flepp, M., Bettex, J.-D., Lüthy, R. & Siegenthaler, W. (1985) Comparison of high performance liquid chromatography and bioassay for determination of ciprofloxacin in serum and urine. Antimicrobial Agents and Chemotherapy, 27, 353-356.
15. Kaartinen, L., Panu, S. & Pyörälä, S. (1997) Pharmacokinetics of enrofloxacin in horses after single intravenous and intramuscular administration. Equine Veterinary Journal, 29, 378-381.
16. Kenney, R.M. & Doig, P.A. (1989) Equine endometrial biopsy. In Current Therapy in Theriogenology 2, 2nd Edn, Ed. Morrow, D.A., pp. 723-729. W.B. Saunders, Philadelphia.
17. Küng, K., Riond, J.-L., Wolfram, S. & Wanner, M. (1993) Comparison of an HPLC and bioassay method to determine antimicrobial concentrations after intravenous and oral administration of enrofloxacin in four dogs. Research in Veterinary Science, 54, 247-248.
18. Langston, V.C., Sedrish, S. & Boothe, D.M. (1996) Disposition of single-dose oral enrofloxacin in the horse. Journal of Veterinary Pharmacology and Therapeutics, 19, 316-319.
19. Liu, P., Müller, M. & Derendorf, H. (2002) Rational dosing of antibiotics: The use of plasma concentrations versus tissue concentrations. International Journal of Antimicrobial Agents, 19, 285-290.
20. Moore, R.M., Schneider, R.K., Kowalski, J., Bramlage, L.R., Mecklenburg, L.M. & Cohn, C.W. (1992) Antimicrobial susceptibility of bacterial isolates from 233 horses with musculoskeletal infection during 1979-89. Equine Veterinary Journal, 24, 450-456.
21. NCCLS (2002) Performance Standard for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard, 2nd Edn. NCCLS document M31-A2. NCCLS, 940 West Valley Road Suite 1400, Wayne, Pennsylvania, Table 2, pp. 56-57.
22. Nix, D.E., Goodwin, S.D., Peloquin, C.A., Rotella, D.L. & Schentag, J.J. (1991) Antibiotic tissue penetration and its relevance: Impact of tissue penetration on infection response. Antimicrobial Agents and Chemotherapy, 35, 1953-1959.
23. Orsini, J.A., Benson, C.E., Spencer, P.A. & Van Miller, E. (1989) Resistance to gentamicin and amikacin of gram-negative organisms isolated from horses. American Journal of Veterinary Research, 50, 923-925.
24. Papich, M.G. & Riviere, J.E. (2001) Fluoroquinolone antimicrobial drugs, Chapter 45. In Veterinary Pharmacology and Therapeutics, 8th Edn., Ed. Adams, H.R., Iowa State University Press, Ames Iowa.
25. Pyörälä, S., Panu, S. & Kaartinen, L. (1994) Single dose pharmacokinetics of ciprofloxacin in horses. Proceedings of European Academy of Veterinary Pharmacology and Therapeutics (EAVPT), 45-46 [Abstract P-18].
26. Vivrette, S.L., Bostian, A., Bermingham, E. & Papich, M.G. (2001) Quinolone-induced arthropathy in neonatal foals. AAEP Proceedings, 47, 376-377.
27. Walker, R.D. (2000) Fluoroquinolones, Chapter 15. In Antimicrobial Therapy in Veterinary Medicine, 3rd Edn. Eds Prescott, J.F., Baggot, J.D. & Walker, R.D., Iowa State University Press, Ames Iowa.
28. Watts, J.L. (Committee Chair) National Committee for Clinical Laboratory Standards (1999) Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard. 19 (No. 11), M31-A.
29. Wright, D.H., Brown, G.H., Peterson, M.L. & Rotschafer, J.C. (2000) Application of fluoroquinolone pharmacodynamics. Journal of Antimicrobial Chemotherapy, 46, 669-683.
30. Yamaoka, K., Nakagawa, T. & Uno, T. (1978) Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of Pharmacokinetics and Biopharmaceutics, 6, 165-175.